News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bristol-Myers Squibb Company (BMY) (JOBS) Still Hungry for Deals After Medarex, Inc. (MEDX) (JOBS)



9/24/2009 7:19:46 AM

Bookmark and Share

Reuters -- Bristol-Myers Squibb Co's $2.4 billion acquisition of biotechnology company Medarex has not quenched its thirst for takeovers as it faces the 2011 patent expiration on Plavix, its biggest-selling drug, the company's head of research and development said.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES